1. Home
  2. ABEO vs NL Comparison

ABEO vs NL Comparison

Compare ABEO & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • NL
  • Stock Information
  • Founded
  • ABEO 1974
  • NL 1891
  • Country
  • ABEO United States
  • NL United States
  • Employees
  • ABEO N/A
  • NL N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • NL Major Chemicals
  • Sector
  • ABEO Health Care
  • NL Industrials
  • Exchange
  • ABEO Nasdaq
  • NL Nasdaq
  • Market Cap
  • ABEO 350.2M
  • NL 320.5M
  • IPO Year
  • ABEO 1980
  • NL N/A
  • Fundamental
  • Price
  • ABEO $5.73
  • NL $6.25
  • Analyst Decision
  • ABEO Strong Buy
  • NL Sell
  • Analyst Count
  • ABEO 6
  • NL 1
  • Target Price
  • ABEO $18.17
  • NL $6.00
  • AVG Volume (30 Days)
  • ABEO 714.3K
  • NL 24.0K
  • Earning Date
  • ABEO 11-13-2025
  • NL 11-05-2025
  • Dividend Yield
  • ABEO N/A
  • NL 5.79%
  • EPS Growth
  • ABEO N/A
  • NL 141.37
  • EPS
  • ABEO 0.99
  • NL 1.10
  • Revenue
  • ABEO $400,000.00
  • NL $152,721,000.00
  • Revenue This Year
  • ABEO N/A
  • NL $15.75
  • Revenue Next Year
  • ABEO $324.71
  • NL $2.44
  • P/E Ratio
  • ABEO $5.80
  • NL $5.50
  • Revenue Growth
  • ABEO N/A
  • NL N/A
  • 52 Week Low
  • ABEO $3.93
  • NL $5.29
  • 52 Week High
  • ABEO $7.54
  • NL $9.42
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 31.45
  • NL 47.71
  • Support Level
  • ABEO $6.53
  • NL $6.00
  • Resistance Level
  • ABEO $6.95
  • NL $6.29
  • Average True Range (ATR)
  • ABEO 0.29
  • NL 0.25
  • MACD
  • ABEO -0.12
  • NL -0.04
  • Stochastic Oscillator
  • ABEO 3.39
  • NL 30.49

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: